Dominic E Dwyer Selected Research

Influenza Vaccines (Influenza Vaccine)

6/2014	Influenza epidemiology, vaccine coverage and vaccine effectiveness in sentinel Australian hospitals in 2013: the Influenza Complications Alert Network.
1/2013	Influenza vaccine effectiveness against hospitalisation with confirmed influenza in the 2010-11 seasons: a test-negative observational study.
10/2011	Effectiveness of H1N1/09 monovalent and trivalent influenza vaccines against hospitalization with laboratory-confirmed H1N1/09 influenza in Australia: a test-negative case control study.
1/2004	Antiviral prophylaxis in the management of an influenza outbreak in an aged care facility.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dominic E Dwyer Research Topics

Disease

46	Human Influenza (Influenza) 01/2023 - 01/2004
27	Infections 01/2024 - 09/2002
9	COVID-19 04/2024 - 09/2020
6	Disease Progression 01/2022 - 06/2004
5	Measles 01/2018 - 01/2006
4	Coinfection 01/2022 - 02/2004
4	Viremia 01/2022 - 07/2005
4	Herpes Zoster 12/2020 - 09/2002
4	Chickenpox 08/2013 - 09/2002
2	Meningoencephalitis 01/2023 - 02/2020
2	Communicable Diseases (Infectious Diseases) 12/2021 - 08/2009
2	Pain (Aches) 01/2019 - 09/2002
2	Demyelinating Diseases (Demyelinating Disease) 08/2013 - 01/2012
2	Pneumonia (Pneumonitis) 01/2013 - 07/2007
2	Inflammation (Inflammations) 01/2013 - 01/2013
2	HIV Infections (HIV Infection) 03/2010 - 02/2004
1	Arbovirus Encephalitis (Epidemic Encephalitis) 01/2024
1	Reinfection 01/2022
1	Mumps 08/2020
1	Parotitis (Parotiditis) 08/2020
1	Coronavirus Infections 07/2020
1	Poliomyelitis (Polio) 01/2020
1	Fatigue 01/2019
1	Chronic Hepatitis C 01/2019
1	Rubella (German Measles) 11/2018
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2018
1	Epstein-Barr Virus Infections 04/2015
1	Exanthema (Rash) 04/2015
1	Common Cold 01/2014
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2013
1	Multiple Sclerosis 06/2012
1	Anemia 01/2012
1	Virus Diseases (Viral Diseases) 05/2011
1	Vomiting 01/2011
1	Infectious Mononucleosis (Glandular Fever) 09/2010
1	Orthomyxoviridae Infections 08/2009
1	Injection Site Reaction 01/2008
1	Lymphopenia (Lymphocytopenia) 11/2005
1	Latent Infection 07/2005
1	Severe Acute Respiratory Syndrome 07/2004
1	Drug-Related Side Effects and Adverse Reactions 06/2004

Drug/Important Bio-Agent (IBA)

23	VaccinesIBA 01/2024 - 01/2006
18	Nucleic AcidsIBA 04/2024 - 09/2002
18	Antiviral Agents (Antivirals)IBA 12/2022 - 09/2002
9	AntibodiesIBA 01/2023 - 09/2002
8	RNA (Ribonucleic Acid)IBA 01/2023 - 03/2010
8	AntigensIBA 01/2022 - 09/2002
8	Oseltamivir (Tamiflu)FDA Link 02/2013 - 01/2009
7	Immunoglobulin G (IgG)IBA 09/2020 - 06/2012
6	DNA (Deoxyribonucleic Acid)IBA 08/2013 - 07/2005
6	Neuraminidase (Sialidase)IBA 02/2013 - 11/2006
4	Anti-Bacterial Agents (Antibiotics)IBA 04/2015 - 03/2013
4	Influenza Vaccines (Influenza Vaccine)FDA Link 06/2014 - 01/2004
3	N-acetyltalosaminuronic acid (NAT)IBA 02/2023 - 09/2020
3	EnzymesIBA 08/2020 - 01/2018
2	CytokinesIBA 01/2013 - 11/2005
1	EpitopesIBA 01/2024
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2023
1	Ribosomal RNAIBA 01/2023
1	FurinIBA 01/2023
1	N-(2-cyanoethylene)urea (BA 1)IBA 01/2022
1	Broadly Neutralizing AntibodiesIBA 01/2022
1	Complementary DNA (cDNA)IBA 12/2021
1	Nucleocapsid ProteinsIBA 01/2021
1	Herpes Zoster VaccineIBA 12/2020
1	Attenuated VaccinesIBA 12/2020
1	Immunoglobulin A (IgA)IBA 09/2020
1	Immunoglobulin M (IgM)IBA 09/2020
1	B 31IBA 01/2019
1	P-30 composite resin (P 30)IBA 01/2017
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 09/2015
1	Stainless Steel (Steel, Stainless)IBA 04/2014
1	PlasticsIBA 04/2014
1	Pertussis ToxinIBA 01/2014
1	Chickenpox Vaccine (Vaccine, Varicella)IBA 05/2013
1	Glycoproteins (Glycoprotein)IBA 04/2013
1	Subunit VaccinesIBA 04/2013
1	AdamantaneIBA 02/2013
1	Zanamivir (Relenza)FDA Link 02/2013
1	Biomarkers (Surrogate Marker)IBA 01/2013
1	ORALIT (ORS)IBA 01/2013
1	AllergensIBA 01/2012
1	OligonucleotidesIBA 08/2011
1	Immunoglobulins (Immunoglobulin)IBA 05/2009
1	Coloring Agents (Dyes)IBA 09/2008
1	Enfuvirtide (Fuzeon)FDA Link 01/2008
1	Surface Antigens (Surface Antigen)IBA 11/2007
1	Neutralizing AntibodiesIBA 09/2007
1	Complement System Proteins (Complement)IBA 07/2007

Therapy/Procedure

8	Therapeutics 01/2022 - 09/2002
5	Mechanical Ventilators (Ventilator) 07/2020 - 07/2009
5	Highly Active Antiretroviral Therapy (HAART) 11/2007 - 01/2003
2	N95 Respirators 05/2014 - 05/2011
1	Immunotherapy 01/2023
1	Art Therapy 01/2022
1	Incubators 01/2022
1	Hand Hygiene 04/2014
1	Ambulatory Care (Outpatient Care) 01/2013
1	Long-Term Care 01/2009
1	Personal Protective Equipment 10/2007